Fairhaven Wealth Management’s Merck MRK Stock Holding History

Fairhaven Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$2.89M	Sell	29,012 -1,019	-3%	-$105K	0.9%	25
2024 Q3	$3.41M	Sell	30,031 -155	-0.5%	-$18.4K	1.04%	19
2024 Q2	$3.74M	Hold	30,186	–	–	1.24%	18
2024 Q1	$3.98M	Sell	30,186 -699	-2%	-$86.2K	1.37%	18
2023 Q4	$3.37M	Buy	30,885 +545	+2%	+$56.6K	1.23%	22
2023 Q3	$3.12M	Buy	30,340 +831	+3%	+$89.6K	1.25%	21
2023 Q2	$3.4M	Buy	+29,509	New	+$3.35M	1.3%	21
2022 Q4	$3.15M	Buy	28,407 +1,288	+5%	+$132K	1.34%	19
2022 Q3	$2.33M	Buy	27,119 +3,451	+15%	+$308K	1.04%	23
2022 Q2	$2.16M	Buy	23,668 +3,915	+20%	+$347K	1.01%	26
2022 Q1	$1.62M	Buy	+19,753	New	+$1.56M	0.66%	32

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fairhaven Wealth Management's MRK Position: Q4 2024 in Review

Fairhaven Wealth Management reduced its Merck (MRK) stake by 3.4% in Q4 2024, selling an estimated $105K and leaving 29,012 shares worth $2.89M. The position accounts for 0.9% of the portfolio, ranked #25.

Fairhaven Wealth Management first reported a position in MRK in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.98M in Q1 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

Fairhaven Wealth Management held 29,012 shares of Merck worth $2.89M as of Q4 2024.
Fairhaven Wealth Management sold 1,019 Merck shares in Q4 2024, an estimated $105K.
Merck made up 0.9% of Fairhaven Wealth Management's portfolio in Q4 2024, its #25 holding.
Fairhaven Wealth Management first reported a position in Merck in Q1 2022 and has held it in 11 quarters since.
Fairhaven Wealth Management's Merck position peaked at $3.98M in Q1 2024.
3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Fairhaven Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.